Exercise of Nil Cost Options under PSP
Updated : 16:11
13 August 2019
Assura plc
Exercise of Nil Cost Options under PSP
Assura plc ("Assura"), the leading primary care property investor and developer announces that on 12 August 2019, Jonathan Murphy exercised his 2016 PSP awards.
The table below shows the number of shares vesting to Mr Murphy, the number of shares sold to satisfy income tax and national insurance liabilities and the number of shares he will receive following the sale.
Number of Shares awarded | Number of shares sold to satisfy income tax and national insurance liabilities | Additional shares sold | Number of shares after shares sold
| |
Jonathan Murphy (CEO) | 218,950 | (102,907) | nil | 116,044 |
The Remuneration Committee of Assura had previously agreed that sufficient shares may be sold by PDMRs to cover the arising income tax and national insurance liabilities. The relevant market price for taxation purposes is £0.651 per share.
As a result of the above, the increase in Mr Murphy's shareholding is as follows:
Shareholding on 9 August 2019 | Shareholding post exercise | |
Jonathan Murphy (CEO) | 2,393,349 | 2,509,393 |
Following the allotment of shares Mr Murphy transferred 98,250 shares into his SIPP. His total beneficial holding remains the same.
The Notification of Dealing Form for the PDMR can be found below.
This notification is made in accordance with the Market Abuse Regulation.
Notification of dealing form
1 | Details of the person discharging managerial responsibilities/person closely associated
| |||||||
a) | Name
| Jonathan Murphy | ||||||
2 | Reason for the notification
| |||||||
a) | Position/status
| CEO | ||||||
b) | Initial notification/ Amendment
| Initial notification | ||||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||||
a) | Name
| Assura plc | ||||||
b) | LEI
| 21380026T19N2Y52XF72 | ||||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||||
a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 10 pence each
GB00BVGBWW93 | ||||||
b) | Nature of the transaction
|
Vesting of share awards under PSP
| ||||||
c) | Price(s) and volume(s)
|
| ||||||
d) | Aggregated information
- Aggregated volume
- Price
|
N/A | ||||||
e) | Date of the transaction
| 12 August 2019 | ||||||
f) | Place of the transaction
| XLON | ||||||
a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 10 pence each
GB00BVGBWW93 | ||||||
b) | Nature of the transaction
| Sale of 102,907 shares to satisfy tax and national insurance liabilities.
| ||||||
c) | Price(s) and volume(s)
|
| ||||||
d) | Aggregated information
- Aggregated volume
- Price
|
| ||||||
e) | Date of the transaction
| 13 August 2019 | ||||||
f) | Place of the transaction
| XLON | ||||||
a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 10 pence each
GB00BVGBWW93 | ||||||
b) | Nature of the transaction
| Transfer of 98,250 shares to Mr Murphy's SIPP.
| ||||||
c) | Price(s) and volume(s)
|
| ||||||
d) | Aggregated information
- Aggregated volume
- Price
|
| ||||||
e) | Date of the transaction
| 13 August 2019 | ||||||
f) | Place of the transaction
| XLON |
- Ends -
For more information, please contact:
Assura plc | Tel: 01925 420660 |
Orla Ball, Company Secretary | |
David Purcell, Head of Financial Reporting | |
Finsbury | Tel: 0207 251 3801 |
Gordon Simpson |
Notes to Editors
Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 31 March 2019, Assura's property portfolio was valued at £1,979 million.
Further information is available at www.assuraplc.com
*EPRA is a registered trademark of the European Public Real Estate Association.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.